{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:28:01Z","timestamp":1754144881909,"version":"3.41.2"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Recurrent epistaxis, which frequently results in iron deficiency anaemia and impaired quality of life, is the most frequent complication of hereditary haemorrhagic telangiectasia (HHT). Specific data to guide rare disease management during a pandemic such as COVID-19 are lacking.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>To better define the impact of the COVID-19 pandemic on HHT, we conducted a retrospective and prospective observational descriptive review of HHT patients in central South Africa. Epistaxis severity scores (ESSs) and haemoglobin (Hb) levels before and after the start of the pandemic were compared. Variables that may have influenced epistaxis severity and anaemia were investigated, viz. (i) mask use, (ii) nasal versus oral swabs to test for SARS-CoV-2, (iii) COVID-19 disease and (iv) its management, (v) COVID-19 vaccines, and (vi) the social impact of the pandemic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-four patients with confirmed HHT were included in the study. Subset analyses revealed a clinically significant change in ESSs (\u2265\u20090.71 minimal important difference) and Hb levels (&gt;\u20092.7% biologic variation) in 6\/11 (54.6%) and 12\/15 (80%) patients. While the median ESS improved in 2\/11 (18.2%) patients, it worsened in 4\/11 (36.4%) patients during the pandemic. However, the changes in the median ESS (2.25 pre-pandemic versus 2.5 during the pandemic; p\u2009=\u20090.38) and Hb level (9.5\u00a0g\/dL pre-pandemic versus 10\u00a0g\/dL during the pandemic; p\u2009=\u20090.38) for the study population were not statistically significant. Clinical and social variables that may influence epistaxis severity and anaemia were identified. Nasal swab testing for SARS-CoV-2 induced epistaxis in 9\/12 (75%) cases and was noted as an important factor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The COVID-19 pandemic has had a clinically significant impact on epistaxis severity and anaemia in some individuals with HHT in central South Africa. Specific strategies are needed to optimise the management of HHT during the COVID-19 and future respiratory pandemics.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03777-2","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T04:15:22Z","timestamp":1752639322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of the COVID-19 pandemic on epistaxis and anaemia in patients with hereditary haemorrhagic telangiectasia (HHT) in central South Africa"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6231-5460","authenticated-orcid":false,"given":"Stephanie Juan\u00e9","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leriska","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9774-334X","authenticated-orcid":false,"given":"Riaz Yakoob","family":"Seedat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"3777_CR1","doi-asserted-by":"publisher","first-page":"989","DOI":"10.7326\/M20-1443","volume":"173","author":"ME Faughnan","year":"2020","unstructured":"Faughnan ME, Mager JJ, Hetts SW, Palda VA, Lang-Robertson K, Buscarini E, et al. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020;173:989\u20131001. https:\/\/doi.org\/10.7326\/M20-1443.","journal-title":"Ann Intern Med"},{"key":"3777_CR2","doi-asserted-by":"publisher","unstructured":"Geisthoff UW, Nguyen HL, Roth A, Seyfert U. How to manage patients with hereditary haemorrhagic telangiectasia. Br J Haematol. 2015;171:443-52. https:\/\/doi.org\/10.1111\/bjh.13606.","DOI":"10.1111\/bjh.13606"},{"key":"3777_CR3","doi-asserted-by":"publisher","unstructured":"McDonald J, Bayrak-Toydemir P, Pyeritz RE. Hereditary hemorrhagic telangiectasia: An overview of diagnosis, management, and pathogenesis. Genet Med. 2011;13:607-16. https:\/\/doi.org\/10.1097\/GIM.0b013e3182136d32.","DOI":"10.1097\/GIM.0b013e3182136d32"},{"key":"3777_CR4","doi-asserted-by":"publisher","unstructured":"Shovlin CL, Simeoni I, Downes K, Frazer ZC, Megy K, Bernabeu-Herrero ME, et al. Mutational and phenotypic characterization of hereditary hemorrhagic telangiectasia. Blood. 2020;136:1907-18. https:\/\/doi.org\/10.1182\/blood.2019004560.","DOI":"10.1182\/blood.2019004560"},{"key":"3777_CR5","doi-asserted-by":"crossref","unstructured":"Pahl K, Kasthuri RS. Hereditary Hemorrhagic Telangiectasia. In: Craig S. Kitchens CMK, Barbara A. Konkle, Michael B. Streiff, David A. Garcia, ed. Consultative Hemostasis and Thrombosis, 4th ed. Philadelphia: Elsevier, 2019,190-206.","DOI":"10.1016\/B978-0-323-46202-0.00011-X"},{"key":"3777_CR6","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1111\/jth.14885","volume":"18","author":"E Gaetani","year":"2020","unstructured":"Gaetani E, Passali GC, Riccioni ME, Tortora A, Pola R, Costamagna G, Multidisciplinary Gemelli Group for HHT, et al. Hereditary haemorrhagic telangiectasia: A disease not to be forgotten during the COVID-19 pandemic. J Thromb Haemost. 2020;18:1799\u2013801. https:\/\/doi.org\/10.1111\/jth.14885.","journal-title":"J Thromb Haemost"},{"key":"3777_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-020-09755-5","author":"A Riera-Mestre","year":"2020","unstructured":"Riera-Mestre A, Iriarte A, Moreno M, Del Castillo R, Lopez-Wolf D. Angiogenesis, hereditary hemorrhagic telangiectasia and COVID-19. Angiogenesis. 2020. https:\/\/doi.org\/10.1007\/s10456-020-09755-5.","journal-title":"Angiogenesis"},{"key":"3777_CR8","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.3390\/jcm10091884","volume":"10","author":"S Marcos","year":"2021","unstructured":"Marcos S, Albinana V, Recio-Poveda L, Tarazona B, Verde-Gonzalez MP, Ojeda-Fernandez L, et al. SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population. J Clin Med. 2021;10:1884\u201396. https:\/\/doi.org\/10.3390\/jcm10091884.","journal-title":"J Clin Med"},{"key":"3777_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s13023-021-02000-2","volume":"16","author":"P Suppressa","year":"2021","unstructured":"Suppressa P, Pagella F, Lenato GM, Gaetani E, Serio I, Masala MS, et al. Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy. Orphanet J Rare Dis. 2021;16:378\u201391. https:\/\/doi.org\/10.1186\/s13023-021-02000-2.","journal-title":"Orphanet J Rare Dis"},{"key":"3777_CR10","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0785-2020","volume":"53","author":"RZ Mariano","year":"2020","unstructured":"Mariano RZ, Pereira MC, Reis F. Hereditary hemorrhagic telangiectasia and COVID-19. Rev Soc Bras Med Trop. 2020;53: e20200785. https:\/\/doi.org\/10.1590\/0037-8682-0785-2020.","journal-title":"Rev Soc Bras Med Trop"},{"key":"3777_CR11","doi-asserted-by":"publisher","first-page":"7941","DOI":"10.4103\/jfmpc.jfmpc_542_22","volume":"11","author":"S Gautam","year":"2022","unstructured":"Gautam S, Mawari G, Kumar N, Garg S, Daga MK. A case report on uneventful anticoagulation and persistence of Type 1 Respiratory Failure post severe COVID-19 infection in a patient of Osler-Weber-Rendu syndrome. J Family Med Prim Care. 2022;11:7941\u20135. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_542_22.","journal-title":"J Family Med Prim Care"},{"key":"3777_CR12","unstructured":"World Health Organization. Director General's opening remarks at the media briefing on COVID-19. 11 March 2020, https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. 2020. Accessed 10 Aug 2021."},{"key":"3777_CR13","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/lary.20818","volume":"120","author":"JB Hoag","year":"2010","unstructured":"Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope. 2010;120:838\u201343. https:\/\/doi.org\/10.1002\/lary.20818.","journal-title":"Laryngoscope"},{"key":"3777_CR14","unstructured":"Drexel University College of Medicine. Epistaxis Severity Score (ESS) for Hereditary Hemorrhagic Telangiectasia. Philadelphia: Drexel University College of Medicine, https:\/\/www2.drexelmed.edu\/HHT-ESS. 2021. Accessed 12 July 2021."},{"key":"3777_CR15","unstructured":"World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, http:\/\/www.who.int. 2011. Accessed 21 Aug 2021."},{"key":"3777_CR16","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/lary.25669","volume":"126","author":"LX Yin","year":"2016","unstructured":"Yin LX, Reh DD, Hoag JB, Mitchell SE, Mathai SC, Robinson GM, et al. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia. Laryngoscope. 2016;126:1029\u201332. https:\/\/doi.org\/10.1002\/lary.25669.","journal-title":"Laryngoscope"},{"key":"3777_CR17","unstructured":"Aarsand AK, Webster C, Coskun A, Gonzales-Lao E, Diaz-Garzon J, Jonker N, et al. The EFLM Biological Variation Database, https:\/\/biologicalvariation.eu\/. 2022. Accessed 13 Feb 2023."},{"key":"3777_CR18","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.3390\/jcm9113571","volume":"9","author":"C Bernabeu","year":"2020","unstructured":"Bernabeu C, Bayrak-Toydemir P, McDonald J, Letarte M. Potential second-hits in hereditary hemorrhagic telangiectasia. J Clin Med. 2020;9:3571\u201391. https:\/\/doi.org\/10.3390\/jcm9113571.","journal-title":"J Clin Med"},{"key":"3777_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s13023-020-01628-w","volume":"15","author":"F Pagella","year":"2020","unstructured":"Pagella F, Lizzio R, Ugolini S, Spinozzi G, Maiorano E, et al. Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab. Orphanet J Rare Dis. 2020;15:350\u20132. https:\/\/doi.org\/10.1186\/s13023-020-01628-w.","journal-title":"Orphanet J Rare Dis"},{"key":"3777_CR20","doi-asserted-by":"publisher","first-page":"102828","DOI":"10.1016\/j.amjoto.2020.102828","volume":"42","author":"E Matti","year":"2021","unstructured":"Matti E, Lizzio R, Spinozzi G, Ugolini S, Maiorano E, Benazzo M, et al. An alternative way to perform diagnostic nasopharyngeal swab for SARS-CoV-2 infection. Am J Otolaryngol. 2021;42:102828\u201331. https:\/\/doi.org\/10.1016\/j.amjoto.2020.102828.","journal-title":"Am J Otolaryngol"},{"key":"3777_CR21","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1016\/j.vaccine.2021.08.055","volume":"39","author":"L Trogstad","year":"2021","unstructured":"Trogstad L, Robertson AH, Mjaaland S, Magnus P. Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: large population-based cohort study. Vaccine. 2021;39:5854\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.055.","journal-title":"Vaccine"},{"key":"3777_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41591-022-02185-4","volume":"29","author":"JV Lazarus","year":"2023","unstructured":"Lazarus JV, Wyka K, White TM, Picchio CA, Gostin LO, Larson HJ, et al. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat Med. 2023;29:366\u201375. https:\/\/doi.org\/10.1038\/s41591-022-02185-4.","journal-title":"Nat Med"},{"key":"3777_CR23","unstructured":"National Institute for Communicable Diseases. COVID-19 Weekly Epidemiology Brief: Week ending 28 January 2023 (Week 4 of 2023), https:\/\/www.nicd.ac.za. 2023. Accessed 1 Mar 2023."},{"key":"3777_CR24","doi-asserted-by":"publisher","first-page":"104370","DOI":"10.1016\/j.ejmg.2021.104370","volume":"65","author":"CL Shovlin","year":"2022","unstructured":"Shovlin CL, Buscarini E, Sabba C, Mager HJ, Kjeldsen AD, Pagella F, et al. The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care. Eur J Med Genet. 2022;65:104370\u201382. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104370.","journal-title":"Eur J Med Genet"},{"key":"3777_CR25","unstructured":"Cure HHT. Guidance from the North American Cure HHT Scientific and Medical Advisory Council. HHT Foundation International, Inc., https:\/\/curehht.org\/wp-content\/uploads\/2021\/04\/Medical-Advisory-Council-Official-Updates-as-of-4-22-2021.pdf. 2021. Accessed 22 Apr 2021."},{"key":"3777_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00851-y","author":"E Suriawinata","year":"2022","unstructured":"Suriawinata E, Mehta KJ. Iron and iron-related proteins in COVID-19. Clin Exp Med. 2022. https:\/\/doi.org\/10.1007\/s10238-022-00851-y.","journal-title":"Clin Exp Med"},{"key":"3777_CR27","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.3390\/jcm10112311","volume":"10","author":"E Gaetani","year":"2021","unstructured":"Gaetani E, Agostini F, Di Martino L, Occhipinti D, Passali GC, Santantonio M, On Behalf Of The Multidisciplinary Gemelli Group For H, et al. Beneficial effects of remote medical care for patients with hereditary hemorrhagic telangiectasia during the COVID-19 pandemic. J Clin Med. 2021;10:2311\u20137. https:\/\/doi.org\/10.3390\/jcm10112311.","journal-title":"J Clin Med"},{"key":"3777_CR28","doi-asserted-by":"publisher","first-page":"10225","DOI":"10.26355\/eurrev_202010_23246","volume":"24","author":"G Marano","year":"2020","unstructured":"Marano G, Gaetani E, Gasbarrini A, Janiri L, Sani G, Mazza M. Mental health and counseling intervention for hereditary hemorrhagic telangiectasia (HHT) during the COVID-19 pandemic: perspectives from Italy. Eur Rev Med Pharmacol Sci. 2020;24:10225\u20137. https:\/\/doi.org\/10.26355\/eurrev_202010_23246.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3777_CR29","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/s41591-022-02028-2","volume":"28","author":"B Penninx","year":"2022","unstructured":"Penninx B, Benros ME, Klein RS, Vinkers CH. How COVID-19 shaped mental health: from infection to pandemic effects. Nat Med. 2022;28:2027\u201337. https:\/\/doi.org\/10.1038\/s41591-022-02028-2.","journal-title":"Nat Med"},{"key":"3777_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.thromres.2017.03.003","volume":"153","author":"S Chaturvedi","year":"2017","unstructured":"Chaturvedi S, Clancy M, Schaefer N, Oluwole O, McCrae KR. Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: a cross-sectional survey. Thromb Res. 2017;153:14\u20138. https:\/\/doi.org\/10.1016\/j.thromres.2017.03.003.","journal-title":"Thromb Res"},{"key":"3777_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12955-017-0586-z","volume":"15","author":"R Zarrabeitia","year":"2017","unstructured":"Zarrabeitia R, Farinas-Alvarez C, Santibanez M, Senaris B, Fontalba A, Botella LM, et al. Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT). Health Qual Life Outcomes. 2017;15:19\u201327. https:\/\/doi.org\/10.1186\/s12955-017-0586-z.","journal-title":"Health Qual Life Outcomes"},{"key":"3777_CR32","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/ajmg.a.35309","volume":"158A","author":"AO Geirdal","year":"2012","unstructured":"Geirdal AO, Dheyauldeen S, Bachmann-Harildstad G, Heimdal K. Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: a population based study. Am J Med Genet A. 2012;158A:1269\u201378. https:\/\/doi.org\/10.1002\/ajmg.a.35309.","journal-title":"Am J Med Genet A"},{"key":"3777_CR33","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s11136-004-7865-y","volume":"13","author":"G Pasculli","year":"2004","unstructured":"Pasculli G, Resta F, Guastamacchia E, Di Gennaro L, Suppressa P, Sabba C. Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease. Qual Life Res. 2004;13:1715\u201323. https:\/\/doi.org\/10.1007\/s11136-004-7865-y.","journal-title":"Qual Life Res"},{"key":"3777_CR34","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.otohns.2006.12.019","volume":"136","author":"UW Geisthoff","year":"2007","unstructured":"Geisthoff UW, Heckmann K, D\u2019Amelio R, Grunewald S, Knobber D, Falkai P, et al. Health-related quality of life in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg. 2007;136:726\u201335. https:\/\/doi.org\/10.1016\/j.otohns.2006.12.019.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"3777_CR35","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/alr.21374","volume":"4","author":"CA Merlo","year":"2014","unstructured":"Merlo CA, Yin LX, Hoag JB, Mitchell SE, Reh DD. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. Int Forum Allergy Rhinol. 2014;4:921\u20135. https:\/\/doi.org\/10.1002\/alr.21374.","journal-title":"Int Forum Allergy Rhinol"},{"key":"3777_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12888-020-02621-0","volume":"20","author":"HS Lee","year":"2020","unstructured":"Lee HS, Chao HH, Huang WT, Chen SC, Yang HY. Psychiatric disorders risk in patients with iron deficiency anemia and association with iron supplementation medications: a nationwide database analysis. BMC Psychiatry. 2020;20:216\u201324. https:\/\/doi.org\/10.1186\/s12888-020-02621-0.","journal-title":"BMC Psychiatry"},{"key":"3777_CR37","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1111\/hae.14486","volume":"28","author":"HT Koekemoer","year":"2022","unstructured":"Koekemoer HT, Joubert J, Nichol RJ, Joubert G, Coetzee MJ. Mental health disorders and health-related quality of life in adults with inherited bleeding disorders in central South Africa. Haemophilia. 2022;28:e64\u20137. https:\/\/doi.org\/10.1111\/hae.14486.","journal-title":"Haemophilia"},{"key":"3777_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-1172-7-33","volume":"7","author":"P Pierucci","year":"2012","unstructured":"Pierucci P, Lenato GM, Suppressa P, Lastella P, Triggiani V, Valerio R, et al. A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study. Orphanet J Rare Dis. 2012;7:33\u201345. https:\/\/doi.org\/10.1186\/1750-1172-7-33.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03777-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03777-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03777-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T04:15:27Z","timestamp":1752639327000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03777-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3777"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03777-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"13 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participateThe research for this study was done in partial fulfilment of the requirements for SJK\u2019s MMed degree (Haematology) at the University of Free State. Ethics approval was obtained from the University of the Free State Health Sciences Research Ethics Committee (UFS-HSD2021\/1385\/2903). The Free State Department of Health granted permission to perform the study. Written informed consent was obtained from all adult participants. Written assent was obtained for all participants under 18 years, while written consent was obtained from their parents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"364"}}